Your browser doesn't support javascript.
loading
Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype.
Schrottmaier, Waltraud C; Pirabe, Anita; Pereyra, David; Heber, Stefan; Hackl, Hubert; Schmuckenschlager, Anna; Brunnthaler, Laura; Santol, Jonas; Kammerer, Kerstin; Oosterlee, Justin; Pawelka, Erich; Treiber, Sonja M; Khan, Abdullah O; Pugh, Matthew; Traugott, Marianna T; Schörgenhofer, Christian; Seitz, Tamara; Karolyi, Mario; Jilma, Bernd; Rayes, Julie; Zoufaly, Alexander; Assinger, Alice.
Afiliação
  • Schrottmaier WC; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Pirabe A; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Pereyra D; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Heber S; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital Vienna, Vienna, Austria.
  • Hackl H; Institute of Physiology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Schmuckenschlager A; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
  • Brunnthaler L; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Santol J; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Kammerer K; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Oosterlee J; Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, General Hospital Vienna, Vienna, Austria.
  • Pawelka E; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Treiber SM; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Khan AO; Department of Medicine IV, Clinic Favoriten, Vienna, Austria.
  • Pugh M; Department of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Traugott MT; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Schörgenhofer C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Seitz T; Department of Medicine IV, Clinic Favoriten, Vienna, Austria.
  • Karolyi M; Department of Clinical Pharmacology, Medical University of Vienna, General Hospital Vienna, Vienna, Austria.
  • Jilma B; Department of Medicine IV, Clinic Favoriten, Vienna, Austria.
  • Rayes J; Department of Medicine IV, Clinic Favoriten, Vienna, Austria.
  • Zoufaly A; Department of Clinical Pharmacology, Medical University of Vienna, General Hospital Vienna, Vienna, Austria.
  • Assinger A; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Front Cardiovasc Med ; 8: 795624, 2021.
Article em En | MEDLINE | ID: mdl-34957266
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article